Please select a video from the list below.
Vascular and Endothelial Biomarkers in PAH
Dr. Ioana Preston reviews the results of 'Oral Treprostinil in Combination with Endothelin Receptor Antagonist and/or PDE-5 Inhibitor for the treatment of PAH (FREEDOM-C2)', presented at the 2016 CHEST Annual Meeting. The study objective was to determine whether in patients with PAH, vascular biomarkers correlate with 6-minute walk distance and NY Heart Association Functional Class.
Recent Video
Most Viewed
Specialties :                    Search :
RESPITE Study Results
RESPITE Study Results Views - 977
ICU Management of PH
ICU Management of PH Views - 145